SIDSCO: A Leader in Preclinical Testing Services
Founded in 2018, SIDSCO (SIDSCO Biomedical Co., Ltd.) specializes in preclinical testing services, providing comprehensive and customized solutions that encompass experimental design, material preparation, study execution, and report generation.
SIDSCO is located in the Luzhu Branch of the Southern Taiwan Science Park and operates state-of-the-art laboratory facilities that meet international standards. As a TAF-certified, GLP-compliant laboratory, SIDSCO is qualified to conduct toxicity studies for pharmaceuticals, health supplements, and regenerative medicine products.
SIDSCO specializes in toxicity studies, cell and molecular biology, animal models, and pathological analysis. The company has successfully developed numerous disease animal models, covering oncology, infectious diseases, cardiovascular conditions, as well as pulmonary, renal, and hepatic disorders—delivering reliable, high-quality preclinical study results for the biotechnology industry. Additionally, SIDSCO offers customized animal model development tailored to specific client needs.
Leadgene Biomedical has completed the full acquisition of SIDSCO, paving the way for deep business integration between the two companies. By combining expertise in diagnostic reagent development, production, and preclinical testing services, this partnership will establish a more comprehensive service ecosystem for the biotechnology industry.
